(MNDY) Monday.Com - Overview
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: IL0011762130
Stock:
Total Rating 33
Risk 42
Buy Signal 0.01
| Risk 5d forecast | |
|---|---|
| Volatility | 58.8% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.89 |
| Alpha | -108.10 |
| Character TTM | |
|---|---|
| Beta | 2.219 |
| Beta Downside | 1.712 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.62% |
| CAGR/Max DD | -0.27 |
EPS (Earnings per Share)
Revenue
Description: MNDY Monday.Com
monday.com Ltd., together with its subsidiaries, develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally. The company provides Work Operating System (Work OS), a cloud-based visual work OS that consists of modular building blocks used and assembled to create software applications and work management tools. Its products include monday work management that manages workflows, projects, and portfolios for team collaboration and productivity; monday CRM, which tracks and manages various sales cycle; monday dev that builds agile product and software development workflows; monday service, which creates seamless connection between service desks and their data; WorkCanvas, a digital whiteboard; and WorkForms, which allows users to create personalized forms or surveys and gain organizational insights. It serves organizations, educational or government institution, and distinct business unit of an organization. The company was formerly known as DaPulse Labs Ltd. and changed its name to monday.com Ltd. in December 2017. monday.com Ltd. was incorporated in 2012 and is headquartered in Tel Aviv, Israel.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 118.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -2.34 > 1.0 |
| NWC/Revenue: 87.19% < 20% (prev 98.42%; Δ -11.23% < -1%) |
| CFO/TA 0.16 > 3% & CFO 341.4m > Net Income 118.7m |
| Net Debt (-1.19b) to EBITDA (73.2m): -16.28 < 3 |
| Current Ratio: 2.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.9m) vs 12m ago 0.97% < -2% |
| Gross Margin: 89.20% > 18% (prev 0.89%; Δ 8830 % > 0.5%) |
| Asset Turnover: 64.98% > 50% (prev 57.67%; Δ 7.31% > 0%) |
| Interest Coverage Ratio: 1024 > 6 (EBITDA TTM 73.2m / Interest Expense TTM 58.0k) |
Altman Z'' 4.41
| A: 0.51 (Total Current Assets 1.79b - Total Current Liabilities 714.9m) / Total Assets 2.11b |
| B: -0.21 (Retained Earnings -433.3m / Total Assets 2.11b) |
| C: 0.03 (EBIT TTM 59.4m / Avg Total Assets 1.90b) |
| D: 1.45 (Book Value of Equity 1.25b / Total Liabilities 859.8m) |
| Altman-Z'' Score: 4.41 = AA |
Beneish M -0.54
| DSRI: 0.75 (Receivables 30.6m/32.3m, Revenue 1.23b/972.0m) |
| GMI: 1.00 (GM 89.20% / 89.33%) |
| AQI: 5.39 (AQ_t 0.05 / AQ_t-1 0.01) |
| SGI: 1.27 (Revenue 1.23b / 972.0m) |
| TATA: -0.11 (NI 118.7m - CFO 341.4m) / TA 2.11b) |
| Beneish M-Score: -0.54 (Cap -4..+1) = D |
What is the price of MNDY shares?
As of February 27, 2026, the stock is trading at USD 75.60 with a total of 2,085,579 shares traded.
Over the past week, the price has changed by -0.53%, over one month by -41.87%, over three months by -47.85% and over the past year by -75.30%.
Over the past week, the price has changed by -0.53%, over one month by -41.87%, over three months by -47.85% and over the past year by -75.30%.
Is MNDY a buy, sell or hold?
Monday.Com has received a consensus analysts rating of 4.48.
Therefore, it is recommended to buy MNDY.
- StrongBuy: 16
- Buy: 8
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MNDY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 135.2 | 78.8% |
| Analysts Target Price | 135.2 | 78.8% |
MNDY Fundamental Data Overview February 21, 2026
P/E Trailing = 33.9286
P/E Forward = 15.5763
P/S = 3.1801
P/B = 2.9926
P/EG = 0.2698
Revenue TTM = 1.23b USD
EBIT TTM = 59.4m USD
EBITDA TTM = 73.2m USD
Long Term Debt = 285.9m USD (estimated: total debt 311.7m - short term 25.8m)
Short Term Debt = 25.8m USD (from shortTermDebt, last quarter)
Debt = 311.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.19b USD (from netDebt column, last quarter)
Enterprise Value = 2.56b USD (3.92b + Debt 311.7m - CCE 1.67b)
Interest Coverage Ratio = 1024 (Ebit TTM 59.4m / Interest Expense TTM 58.0k)
EV/FCF = 8.00x (Enterprise Value 2.56b / FCF TTM 320.5m)
FCF Yield = 12.50% (FCF TTM 320.5m / Enterprise Value 2.56b)
FCF Margin = 26.02% (FCF TTM 320.5m / Revenue TTM 1.23b)
Net Margin = 9.64% (Net Income TTM 118.7m / Revenue TTM 1.23b)
Gross Margin = 89.20% ((Revenue TTM 1.23b - Cost of Revenue TTM 133.1m) / Revenue TTM)
Gross Margin QoQ = 88.82% (prev 88.71%)
Tobins Q-Ratio = 1.22 (Enterprise Value 2.56b / Total Assets 2.11b)
Interest Expense / Debt = 0.12% (Interest Expense 361.0k / Debt 311.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 46.9m (EBIT 59.4m * (1 - 21.00%))
Current Ratio = 2.50 (Total Current Assets 1.79b / Total Current Liabilities 714.9m)
Debt / Equity = 0.25 (Debt 311.7m / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = -16.28 (Net Debt -1.19b / EBITDA 73.2m)
Debt / FCF = -3.72 (Net Debt -1.19b / FCF TTM 320.5m)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 118.7m / Total Assets 2.11b)
RoE = 9.88% (Net Income TTM 118.7m / Total Stockholder Equity 1.20b)
RoCE = 3.99% (EBIT 59.4m / Capital Employed (Equity 1.20b + L.T.Debt 285.9m))
RoIC = 3.95% (NOPAT 46.9m / Invested Capital 1.19b)
WACC = 13.06% (E(3.92b)/V(4.23b) * Re(14.09%) + D(311.7m)/V(4.23b) * Rd(0.12%) * (1-Tc(0.21)))
Discount Rate = 14.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.27%
[DCF] Terminal Value 66.22% ; FCFF base≈310.6m ; Y1≈376.6m ; Y5≈616.0m
[DCF] Fair Price = 122.1 (EV 5.10b - Net Debt -1.19b = Equity 6.29b / Shares 51.6m; r=13.06% [WACC]; 5y FCF grow 22.68% → 2.90% )
EPS Correlation: 83.31 | EPS CAGR: 154.1% | SUE: 1.51 | # QB: 10
Revenue Correlation: 99.12 | Revenue CAGR: 34.95% | SUE: 4.0 | # QB: 15
EPS next Quarter (2026-03-31): EPS=0.94 | Chg7d=-0.133 | Chg30d=-0.136 | Revisions Net=-19 | Analysts=22
EPS current Year (2026-12-31): EPS=4.06 | Chg7d=-0.785 | Chg30d=-0.822 | Revisions Net=-21 | Growth EPS=-7.6% | Growth Revenue=+18.4%
EPS next Year (2027-12-31): EPS=5.06 | Chg7d=-1.014 | Chg30d=-1.120 | Revisions Net=-16 | Growth EPS=+24.5% | Growth Revenue=+17.6%
[Analyst] Revisions Ratio: -0.90 (1 Up / 20 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.1% (Discount Rate 14.1% - Earnings Yield 2.9%)
[Growth] Growth Spread = +9.1% (Analyst 20.2% - Implied 11.1%)
P/E Forward = 15.5763
P/S = 3.1801
P/B = 2.9926
P/EG = 0.2698
Revenue TTM = 1.23b USD
EBIT TTM = 59.4m USD
EBITDA TTM = 73.2m USD
Long Term Debt = 285.9m USD (estimated: total debt 311.7m - short term 25.8m)
Short Term Debt = 25.8m USD (from shortTermDebt, last quarter)
Debt = 311.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.19b USD (from netDebt column, last quarter)
Enterprise Value = 2.56b USD (3.92b + Debt 311.7m - CCE 1.67b)
Interest Coverage Ratio = 1024 (Ebit TTM 59.4m / Interest Expense TTM 58.0k)
EV/FCF = 8.00x (Enterprise Value 2.56b / FCF TTM 320.5m)
FCF Yield = 12.50% (FCF TTM 320.5m / Enterprise Value 2.56b)
FCF Margin = 26.02% (FCF TTM 320.5m / Revenue TTM 1.23b)
Net Margin = 9.64% (Net Income TTM 118.7m / Revenue TTM 1.23b)
Gross Margin = 89.20% ((Revenue TTM 1.23b - Cost of Revenue TTM 133.1m) / Revenue TTM)
Gross Margin QoQ = 88.82% (prev 88.71%)
Tobins Q-Ratio = 1.22 (Enterprise Value 2.56b / Total Assets 2.11b)
Interest Expense / Debt = 0.12% (Interest Expense 361.0k / Debt 311.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = 46.9m (EBIT 59.4m * (1 - 21.00%))
Current Ratio = 2.50 (Total Current Assets 1.79b / Total Current Liabilities 714.9m)
Debt / Equity = 0.25 (Debt 311.7m / totalStockholderEquity, last quarter 1.25b)
Debt / EBITDA = -16.28 (Net Debt -1.19b / EBITDA 73.2m)
Debt / FCF = -3.72 (Net Debt -1.19b / FCF TTM 320.5m)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 118.7m / Total Assets 2.11b)
RoE = 9.88% (Net Income TTM 118.7m / Total Stockholder Equity 1.20b)
RoCE = 3.99% (EBIT 59.4m / Capital Employed (Equity 1.20b + L.T.Debt 285.9m))
RoIC = 3.95% (NOPAT 46.9m / Invested Capital 1.19b)
WACC = 13.06% (E(3.92b)/V(4.23b) * Re(14.09%) + D(311.7m)/V(4.23b) * Rd(0.12%) * (1-Tc(0.21)))
Discount Rate = 14.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.27%
[DCF] Terminal Value 66.22% ; FCFF base≈310.6m ; Y1≈376.6m ; Y5≈616.0m
[DCF] Fair Price = 122.1 (EV 5.10b - Net Debt -1.19b = Equity 6.29b / Shares 51.6m; r=13.06% [WACC]; 5y FCF grow 22.68% → 2.90% )
EPS Correlation: 83.31 | EPS CAGR: 154.1% | SUE: 1.51 | # QB: 10
Revenue Correlation: 99.12 | Revenue CAGR: 34.95% | SUE: 4.0 | # QB: 15
EPS next Quarter (2026-03-31): EPS=0.94 | Chg7d=-0.133 | Chg30d=-0.136 | Revisions Net=-19 | Analysts=22
EPS current Year (2026-12-31): EPS=4.06 | Chg7d=-0.785 | Chg30d=-0.822 | Revisions Net=-21 | Growth EPS=-7.6% | Growth Revenue=+18.4%
EPS next Year (2027-12-31): EPS=5.06 | Chg7d=-1.014 | Chg30d=-1.120 | Revisions Net=-16 | Growth EPS=+24.5% | Growth Revenue=+17.6%
[Analyst] Revisions Ratio: -0.90 (1 Up / 20 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.1% (Discount Rate 14.1% - Earnings Yield 2.9%)
[Growth] Growth Spread = +9.1% (Analyst 20.2% - Implied 11.1%)